» Authors » Yanina Ghiglione

Yanina Ghiglione

Explore the profile of Yanina Ghiglione including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 251
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baquero L, Stover S, Armani-Tourret M, Armani Tourret M, Perbeils A, Perbelis A, et al.
AIDS . 2024 Nov; 39(4):344-355. PMID: 39591539
Objective: To characterize the immune functionality and phenotype and the proviral composition of a cohort of young adults with perinatally acquired HIV (p-YA) from Argentina. Design: Cross-sectional study of 18...
2.
Osegueda A, Baquero L, Casanova A, Cruces L, Fisher K, Mendez C, et al.
Ann Intern Med . 2024 Oct; 177(11):1595-1598. PMID: 39374525
No abstract available.
3.
Osegueda A, Polo M, Baquero L, Urioste A, Ghiglione Y, Paz S, et al.
Open Forum Infect Dis . 2023 Dec; 10(12):ofad591. PMID: 38107019
Background: Liver fibrosis is a leading cause of morbimortality in people with HIV/hepatitis C virus (HCV). Natural killer (NK) cells are linked with amelioration of liver fibrosis; however, NK cells...
4.
Trifone C, Baquero L, Czernikier A, Benencio P, Leng L, Laufer N, et al.
Viruses . 2022 Oct; 14(10). PMID: 36298774
In this study, we evaluate the role of the MIF/CD74 axis in the functionality of CD4 T lymphocytes (CD4TL) during HIV infection. MDMs from healthy donors were infected with a...
5.
Rubione J, Perez P, Czernikier A, Duette G, Pereyra Gerber F, Salido J, et al.
mBio . 2022 Aug; 13(4):e0061122. PMID: 35943163
Combined Antiretroviral therapy (cART) suppresses HIV replication but fails to eradicate the virus, which persists in a small pool of long-lived latently infected cells. Immune activation and residual inflammation during...
6.
Giannone D, Vecchione M, Czernikier A, Polo M, Gonzalez Polo V, Cruces L, et al.
J Infect . 2022 May; 85(3):334-363. PMID: 35636532
No abstract available.
7.
Salido J, Czernikier A, Trifone C, Polo M, Figueroa M, Urioste A, et al.
Pathog Immun . 2022 Jan; 6(2):60-89. PMID: 34988339
Background: Combined antiretroviral treatment (cART) for HIV infection is highly effective in controlling viral replication. However, it cannot achieve a sterilizing cure. Several strategies have been proposed to achieve a...
8.
Turk G, Seiger K, Lian X, Sun W, Parsons E, Gao C, et al.
Ann Intern Med . 2021 Nov; 175(1):95-100. PMID: 34781719
Background: A sterilizing cure of HIV-1 infection has been reported in 2 persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous for the...
9.
Ghiglione Y, Polo M, Urioste A, Rhodes A, Czernikier A, Trifone C, et al.
Open Forum Infect Dis . 2020 May; 7(5):ofaa115. PMID: 32391403
Background: Hepatitis C virus (HCV) coinfection among people with human immunodeficiency virus (HIV) might perturb immune function and HIV persistence. We aimed to evaluate the impact of HCV clearance with...
10.
Salido J, Ruiz M, Trifone C, Figueroa M, Caruso M, Gherardi M, et al.
Front Immunol . 2018 Nov; 9:2443. PMID: 30405632
Since anti-HIV treatment cannot cure the infection, many strategies have been proposed to eradicate the viral reservoir, which still remains as a major challenge. The success of some of these...